$29.71
0.150.51%
At close: -
$29.71
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Collegium Pharmaceutical Earnings Estimates, EPS & Revenue | NASDAQ:COLL | Benzinga
Collegium Pharmaceutical reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$1.530
Quarterly Revenue Estimate
$181.59M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$631.45M
Analyze the earnings history of Collegium Pharmaceutical using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| COLL | Collegium Pharmaceutical | $1.45 | $1.53 | — | — | $144.92M | $181.59M | — | — | 05/08/2025 | Get Alert |
| COLL | Collegium Pharmaceutical | $1.58 | $1.54 | $1.75 | 13.64% | $149.75M | $179.68M | $181.95M | 1.26% | 02/27/2025 | Get Alert |
| COLL | Collegium Pharmaceutical | $1.34 | $1.59 | $1.61 | 1.26% | $136.71M | $155.57M | $159.30M | 2.40% | 11/07/2024 | Get Alert |
| COLL | Collegium Pharmaceutical | $1.26 | $1.51 | $1.62 | 7.28% | $135.55M | $143.94M | $145.28M | 0.93% | 08/08/2024 | Get Alert |
| COLL | Collegium Pharmaceutical | $1.32 | $0.75 | $1.45 | 93.33% | $144.77M | $147.49M | $144.92M | -1.74% | 05/09/2024 | Get Alert |
| COLL | Collegium Pharmaceutical | $1.09 | $0.66 | $1.58 | 139.39% | $129.62M | $147.82M | $149.75M | 1.30% | 02/22/2024 | Get Alert |
| COLL | Collegium Pharmaceutical | $1.10 | $0.52 | $1.34 | 157.69% | $127.01M | $138.53M | $136.71M | -1.31% | 11/07/2023 | Get Alert |
| COLL | Collegium Pharmaceutical | $0.33 | $1.22 | $1.26 | 3.28% | $123.55M | $137.98M | $135.55M | -1.76% | 08/03/2023 | Get Alert |
| COLL | Collegium Pharmaceutical | $0.42 | $0.31 | $1.32 | 325.81% | $83.75M | $138.47M | $144.77M | 4.55% | 05/04/2023 | Get Alert |
| COLL | Collegium Pharmaceutical | -$0.51 | -$0.14 | $1.09 | 878.57% | $27.36M | $125.19M | $129.62M | 3.54% | 02/23/2023 | Get Alert |
| COLL | Collegium Pharmaceutical | $0.22 | -$0.13 | $1.10 | 946.15% | $78.84M | $124.45M | $127.01M | 2.06% | 11/03/2022 | Get Alert |
| COLL | Collegium Pharmaceutical | $0.27 | $1.45 | $0.33 | -77.24% | $82.94M | $121.80M | $123.55M | 1.44% | 08/04/2022 | Get Alert |
| COLL | Collegium Pharmaceutical | $0.41 | $0.90 | $0.42 | -53.33% | $87.72M | $78.88M | $83.75M | 6.18% | 05/10/2022 | Get Alert |
| COLL | Collegium Pharmaceutical | $0.20 | $1.04 | -$0.51 | -149.04% | $76.27M | $81.61M | $27.36M | -66.47% | 02/24/2022 | Get Alert |
| COLL | Collegium Pharmaceutical | $0.32 | — | $0.22 | — | $79.18M | $84.89M | $78.84M | -7.12% | 11/04/2021 | Get Alert |
| COLL | Collegium Pharmaceutical | $0.23 | $0.36 | $0.27 | -25.00% | $78.06M | $84.77M | $82.94M | -2.16% | 08/05/2021 | Get Alert |
| COLL | Collegium Pharmaceutical | $0.01 | $0.30 | $0.41 | 36.67% | $76.51M | $81.87M | $87.72M | 7.15% | 05/06/2021 | Get Alert |
| COLL | Collegium Pharmaceutical | -$0.07 | $0.29 | $0.20 | -31.03% | $74.20M | $77.41M | $76.27M | -1.47% | 02/25/2021 | Get Alert |
| COLL | Collegium Pharmaceutical | -$0.18 | $0.22 | $0.32 | 45.45% | $72.94M | $77.43M | $79.18M | 2.25% | 11/05/2020 | Get Alert |
| COLL | Collegium Pharmaceutical | -$0.14 | $0.20 | $0.23 | 15.00% | $75.04M | $74.40M | $78.06M | 4.92% | 08/05/2020 | Get Alert |
| COLL | Collegium Pharmaceutical | -$0.29 | $0.37 | $0.01 | -97.30% | $74.52M | $77.08M | $76.51M | -0.74% | 05/07/2020 | Get Alert |
Collegium Pharmaceutical (COLL) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $1.75 | $1.54 | 13.6 % |
| Q3 | 2024-11-07 | $1.61 | $1.59 | 1.26 % |
| Q2 | 2024-08-08 | $1.62 | $1.51 | 7.28 % |
| Q1 | 2024-05-09 | $1.45 | $0.75 | 93.3 % |
Collegium Pharmaceutical (COLL) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $181.95M | $179.68M | 1.26 % |
| Q3 | 2024-11-07 | $159.30M | $155.57M | 2.40 % |
| Q2 | 2024-08-08 | $145.28M | $143.94M | 0.93 % |
| Q1 | 2024-05-09 | $144.92M | $147.49M | -1.74 % |
FAQ
When is Collegium Pharmaceutical (NASDAQ:COLL) reporting earnings?
Collegium Pharmaceutical (COLL) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on February 27, 2025 for Q4.
What were the latest earnings per share (EPS) for Collegium Pharmaceutical (NASDAQ:COLL)?
The Actual EPS was $1.75, which beat the estimate of $1.54.
What were Collegium Pharmaceutical’s (NASDAQ:COLL) revenues?
The Actual Revenue was $181.9M, which beat the estimate of $179.7M.
Browse earnings estimates, EPS, and revenue on all stocks.